These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38396947)

  • 1. CHST4 Gene as a Potential Predictor of Clinical Outcome in Malignant Pleural Mesothelioma.
    Okado S; Kato T; Hanamatsu Y; Emoto R; Imamura Y; Watanabe H; Kawasumi Y; Kadomatsu Y; Ueno H; Nakamura S; Mizuno T; Takeuchi T; Matsui S; Chen-Yoshikawa TF
    Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LAG3 is an independent prognostic biomarker and potential target for immune checkpoint inhibitors in malignant pleural mesothelioma: a retrospective study.
    Arimura K; Hiroshima K; Nagashima Y; Nakazawa T; Ogihara A; Orimo M; Sato Y; Katsura H; Kanzaki M; Kondo M; Tagaya E
    BMC Cancer; 2023 Dec; 23(1):1206. PubMed ID: 38062416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KIAA0101 in Malignant Pleural Mesothelioma: A Potential Diagnostic and Prognostic Marker.
    Lin P; Zhao Y; Li X; Liang Z
    Comb Chem High Throughput Screen; 2022; 25(9):1498-1506. PubMed ID: 34238152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-98 is a prognostic factor for asbestos-induced mesothelioma.
    Kim K; Ko Y; Oh H; Ha M; Kang J; Kwon EJ; Kang JW; Kim Y; Heo HJ; Kim G; Kim JW; Kim YH
    J Toxicol Environ Health A; 2020 Feb; 83(3):126-134. PubMed ID: 32114955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of glycolysis genes signature for predicting prognosis in malignant pleural mesothelioma by bioinformatics and machine learning.
    Xiao Y; Huang W; Zhang L; Wang H
    Front Endocrinol (Lausanne); 2022; 13():1056152. PubMed ID: 36523602
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and clinical significance of COL1A1 and COL1A2 genes in malignant pleural mesothelioma tissues].
    Li B; Pu YQ; Li ZL; Zhao Y; Zi JJ; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2022 Jul; 40(7):487-494. PubMed ID: 35915937
    [No Abstract]   [Full Text] [Related]  

  • 7. Peripheral Blood DNA Methylation as Potential Biomarker of Malignant Pleural Mesothelioma in Asbestos-Exposed Subjects.
    Guarrera S; Viberti C; Cugliari G; Allione A; Casalone E; Betti M; Ferrante D; Aspesi A; Casadio C; Grosso F; Libener R; Piccolini E; Mirabelli D; Dianzani I; Magnani C; Matullo G
    J Thorac Oncol; 2019 Mar; 14(3):527-539. PubMed ID: 30408567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale analysis of BAP1 expression reveals novel associations with clinical and molecular features of malignant pleural mesothelioma.
    De Rienzo A; Chirieac LR; Hung YP; Severson DT; Freyaldenhoven S; Gustafson CE; Dao NT; Meyerovitz CV; Oster ME; Jensen RV; Yeap BY; Bueno R; Richards WG
    J Pathol; 2021 Jan; 253(1):68-79. PubMed ID: 32944962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated PDGFRB gene copy number gain is prognostic for improved survival outcomes in resected malignant pleural mesothelioma.
    Tsao AS; Harun N; Fujimoto J; Devito V; Lee JJ; Kuhn E; Mehran R; Rice D; Moran C; Hong WK; Shen L; Suraokar M; Wistuba I
    Ann Diagn Pathol; 2014 Jun; 18(3):140-5. PubMed ID: 24747001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-staining Immunohistochemistry Reveals in Malignant Pleural Mesothelioma the Coexpression of ERCC1 and RRM1 as a Frequent Biological Event Related to Poorer Survival.
    Zito Marino F; Baselice S; Erra S; Ronchi A; Montella M; Morgillo F; Vicidomini G; Santini M; Poziello G; Cozzolino I; Accardo M; Franco R
    Appl Immunohistochem Mol Morphol; 2021 Mar; 29(3):231-238. PubMed ID: 32842027
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Cheng YY; Mok E; Tan S; Leygo C; McLaughlin C; George AM; Reid G
    Dis Markers; 2017; 2017():2536187. PubMed ID: 29386699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-7 is expressed in malignant mesothelioma and has a prognostic value.
    Mai HL; Deshayes S; Nguyen TV; Dehame V; Chéné AL; Brouard S; Blanquart C
    Mol Oncol; 2022 Oct; 16(20):3606-3619. PubMed ID: 36054746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of CD24 gene in human malignant pleural mesothelioma and its relationship with prognosis].
    Li B; Zhou CX; Pu YQ; Qiu L; Mei W; Xiong W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Mar; 41(3):168-176. PubMed ID: 37006141
    [No Abstract]   [Full Text] [Related]  

  • 14. [Prognostic significance and immune cell infiltration analysis of differentially expressed genes in malignant pleural mesothelioma].
    Wang N; Zhao QN; Yuan Q; Zhu BL; Wu W
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2023 Sep; 41(9):641-647. PubMed ID: 37805421
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of the M-CSF/IL-34/CSF-1R pathway in malignant pleural mesothelioma.
    Blondy T; d'Almeida SM; Briolay T; Tabiasco J; Meiller C; Chéné AL; Cellerin L; Deshayes S; Delneste Y; Fonteneau JF; Boisgerault N; Bennouna J; Grégoire M; Jean D; Blanquart C
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression and clinical significance of SETD2 in maligant pleural mesothelioma].
    Yu M; Yu M; Zhu LJ; Yuan XY; Zhang X
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Feb; 39(2):91-98. PubMed ID: 33691361
    [No Abstract]   [Full Text] [Related]  

  • 17. Multiplex Soluble Biomarker Analysis from Pleural Effusion.
    Javadi J; Dobra K; Hjerpe A
    Biomolecules; 2020 Jul; 10(8):. PubMed ID: 32731396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Role of Programmed Cell Death 1 Ligand 1 in Resectable Pleural Mesothelioma.
    Lee HS; Hamaji M; Palivela N; Jang HJ; Splawn T; Ramos D; Lee AK; Raghuram AC; Ramineni M; Amos CI; Ripley RT; Burt BM
    Ann Thorac Surg; 2021 Nov; 112(5):1575-1583. PubMed ID: 33248997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative genetic analysis of a rare synchronous collision tumor composed of malignant pleural mesothelioma and primary pulmonary adenocarcinoma.
    Naka T; Hatanaka Y; Marukawa K; Okada H; Hatanaka KC; Sakakibara-Konishi J; Oizumi S; Hida Y; Kaga K; Mitsuhashi T; Matsuno Y
    Diagn Pathol; 2016 Apr; 11():38. PubMed ID: 27091358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The usefulness of biomarkers in diagnosis of asbestos-induced malignant pleural mesothelioma.
    Tanrıverdi Z; Meteroglu F; Yüce H; Şenyiğit A; Işcan M; Unüvar S
    Hum Exp Toxicol; 2021 Nov; 40(11):1817-1824. PubMed ID: 33998299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.